Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials

Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials

Objective Our objective of this study was to analyse all oncological clinical trials using regorafenib to create a complete risk/benefit profile for the drug.Background Creating a novel chemotherapy is costly both in time and capital spent for drug manufacturers. To regenerate what they’ve spent, dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Matt Vassar, Vinay Prasad, Ryan McIntire, Alyson Haslam, Brody Dennis, Chance Bratten, Griffin K Hughes, Andriana M Peña, Chase Ladd, Brooke Gardner, William Nowlin, Reagan Livingston, Jordan Tuia
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/3/1/e000229.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items